{
    "id": 25456,
    "fullName": "ERBB2 K753E",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "ERBB2 (HER2) K753E lies within the protein kinase domain of the Erbb2 (Her2) protein (UniProt.org). K753E does not result in increased phosphorylation of Erbb2 (Her2) or downstream PLC-gamma, and results in similar tumor formation to wild-type Erbb2 (Her2) in mouse models, however, results in increased Egfr phosphorylation and is associated with resistance to some Erbb2 (Her2) inhibitors (PMID: 27697991, PMID: 29389942).",
            "references": [
                {
                    "id": 6720,
                    "pubMedId": 27697991,
                    "title": "Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27697991"
                },
                {
                    "id": 14657,
                    "pubMedId": 29389942,
                    "title": "Structural investigations on mechanism of lapatinib resistance caused by HER-2 mutants.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29389942"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2064,
        "geneSymbol": "ERBB2",
        "terms": [
            "ERBB2",
            "CD340",
            "HER-2",
            "HER-2/neu",
            "HER2",
            "MLN 19",
            "NEU",
            "NGL",
            "TKR1"
        ]
    },
    "variant": "K753E",
    "createDate": "10/06/2016",
    "updateDate": "10/21/2019",
    "referenceTranscriptCoordinates": {
        "id": 170563,
        "transcript": "NM_004448",
        "gDna": "chr17:g.39723960A>G",
        "cDna": "c.2257A>G",
        "protein": "p.K753E",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 8755,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed human breast cells expressing ERBB2 (HER2) K753E were resistant to Herceptin (trastuzumab) in culture (PMID: 27697991).",
            "molecularProfile": {
                "id": 26418,
                "profileName": "ERBB2 K753E"
            },
            "therapy": {
                "id": 947,
                "therapyName": "Trastuzumab",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 6720,
                    "pubMedId": 27697991,
                    "title": "Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27697991"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8757,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed human breast cells expressing ERBB2 (HER2) K753 were sensitive to Nerlynx (neratinib) in culture, resulting in decreased colony formation (PMID: 27697991).",
            "molecularProfile": {
                "id": 26418,
                "profileName": "ERBB2 K753E"
            },
            "therapy": {
                "id": 828,
                "therapyName": "Neratinib",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6720,
                    "pubMedId": 27697991,
                    "title": "Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27697991"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8756,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed human breast cells expressing ERBB2 (HER2) K753E were resistant to Tykerb (lapatinib) in culture (PMID: 27697991).",
            "molecularProfile": {
                "id": 26418,
                "profileName": "ERBB2 K753E"
            },
            "therapy": {
                "id": 787,
                "therapyName": "Lapatinib",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 6720,
                    "pubMedId": 27697991,
                    "title": "Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27697991"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26418,
            "profileName": "ERBB2 K753E",
            "profileTreatmentApproaches": [
                {
                    "id": 10641,
                    "name": "Neratinib",
                    "profileName": "ERBB2 K753E"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 170564,
            "transcript": "NM_001289937",
            "gDna": "chr17:g.39723960A>G",
            "cDna": "c.2257A>G",
            "protein": "p.K753E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 170563,
            "transcript": "NM_004448",
            "gDna": "chr17:g.39723960A>G",
            "cDna": "c.2257A>G",
            "protein": "p.K753E",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}